Duhay Francis sold $1K of NVNO
Duhay Francis sold 140 shares of enVVeno Medical Corp (NVNO) at $10.30 on 2026-06-11 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
A director open-market sale of 140 shares occurred on 2026-06-11; the plan is pre-arranged under Rule 10b5-1, which generally limits interpretive weight.
Market read
Primarily a sentiment/flow datapoint; no new fundamental catalyst is disclosed.
What to watch
The article provides only the transaction details; without context on total insider holdings, frequency of sales, or any concurrent corporate events, the signal is weak.
Background
The article summarizes an SEC Form 4 insider transaction for enVVeno Medical Corp (NVNO).
Ticker impact
Director Duhay Francis sold 140 shares of enVVeno Medical Corp on 2026-06-11 under a pre-arranged 10b5-1 plan, per Form 4.
Low near-term impact; any reaction is likely limited to sentiment/flow rather than a new catalyst.
The filing is an SEC Form 4 insider transaction with a stated 10b5-1 pre-arranged plan and small share count/value, with no accompanying operational or regulatory development in the text.
Market effects
No sector read-through; this is company-specific insider transaction data only.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can still coincide with internal caution; traders may watch for follow-on sales or other filings.
Key entities
- issuerenVVeno Medical Corp
Company whose director insider sale is disclosed on SEC Form 4.
- insiderDuhay Francis
Director who sold 140 shares under a pre-arranged 10b5-1 plan.